Protara Therapeutics, Inc. — Director's Dealing 2020

Sep 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protara Therapeutics, Inc. ("TARA")
CIK: 0001359931
Period of Report: 2020-09-24

Reporting Person: Opaleye Management Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-24	Common Stock, par value $0.001 per share	P	100000	$16.87	Acquired	100000	Indirect
2020-09-24	Common Stock, par value $0.001 per share	P	200000	$16.87	Acquired	2408472	Indirect

Footnotes

F1: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

F2: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.